rifamycin O,
Rifamycin O,
Rifomycin O,
RIFAMYCIN-O,
14487-05-9,
EINECS 238-493-1,
NSC 182391,
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, gamma-lactone,
UNII-Z67LEM9P1W,
((1,2,6,9-Tetrahydro-5,9,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,11-trioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)acetic acid gamma-lactone, 21-acetate,
Acetic acid, ((1,2,6,9-tetrahydro-5,9,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,11-trioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)-, gamma-lactone, 21-acetate,
Spiro(1,3-dioxolane-2,9'(6'H)-(2,7)(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan)-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-, 21'-acetate,
Z67LEM9P1W,
NSC182391,
C39H47NO14,
SCHEMBL18494827,
CHEBI:16324,
RAFHKEAPVIWLJC-KQOHHTLASA-N,
LMPK05000004,
AKOS024255722,
KS-1408,
LS-146117,
C01849,
487R059,
(trihydroxy-methoxy-heptamethyl-4-tetraoxo-spiro[1,3-dioxolane-2,[?]-[?]]yl) acetate,
(2'S,12'Z,14'E,16'S,17'S,18'R,19'R,20'R,21'S,22'R,23'S,24'E)-5',17',19'-trihydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-1',4,6',11'-tetraoxo-1',2'-dihydro-6'H-spiro[1,3-dioxolane-2,9'-[2,7](epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan]-21'-yl acetate,
C39-H47-N-O14,
CID5280468,
P135,
Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, .gamma.-lactone,
Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-, 21'-acetate,